SCCAB-Pilot: Stroke and Carotid-Cerebral Vascular Disease After CABG - a Pilot Observation

Sponsor
Ruijin Hospital (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05036044
Collaborator
(none)
500
1
8.9
56.4

Study Details

Study Description

Brief Summary

Review the data of patients who underwent coronary artery bypass grafting (CABG) at the Department of Cardiovascular Surgery in Ruijin hospital from March 2020 to March 2021, including medical history, head and neck CTA, head CT scan, and early postoperative (within 7 days after surgery) neurological complications (defined as a composite of stroke, delayed awakening and severe delirium) . Case-control and retrospective cohorts were built to explore risk factors of early postoperative neurological complications, And its association with baseline carotid-cerebral vascular disease.

Describe the epidemiological data of early postoperative neurological complications (stroke, delayed awakening, and severe delirium) after CABG surgery (within 7 days after surgery); explore independent risk factors of compound neurological complications, build predictive models; compare the effects of carotid-cerebral artery disease on early postoperative compound neurological complications.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    500 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    A Pilot Retrospective Observational Study of Associations Between Early Neurological Complications(Including Stroke)and Carotid-cerebral Vascular Disease Among Patients After Coronary Artery Bypass Grafting
    Actual Study Start Date :
    Sep 4, 2021
    Anticipated Primary Completion Date :
    Jun 1, 2022
    Anticipated Study Completion Date :
    Jun 1, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    With moderate or severe carotid-cerebral artery disease

    moderate (stenosis 50-69%) or severe (stenosis 70-100%) carotid-cerebral artery disease

    Without moderate or severe carotid-cerebral artery disease

    mild (stenosis 30-49%) or no (stenosis 0-29%) carotid-cerebral artery disease

    Outcome Measures

    Primary Outcome Measures

    1. the incidence of 7-day neurological complications [within 7 days post-CABG]

      a composite of stroke, delayed awakening, severe delirium

    2. the incidence of 7-day stroke [within 7 days post-CABG]

      including cerebral infarction, cerebral hemorrhage, and hypoxic-ischemic encephalopathy

    3. the incidence of delayed awakening [within 48 hours post-CABG]

      post-surgery patient does not wake up at 48 hours after withdrawing sedative

    4. the incidence of severe delirium [within 7 days post-CABG]

      ICU CAM-II score≥2 points

    Secondary Outcome Measures

    1. the incidence of All-cause death [7 days, 30 days and 1 year post-CABG]

      Death from any cause

    2. the incidence of CV-death [7 days, 30 days and 1 year post-CABG]

      Including death resulting from an acute myocardial infarction , sudden cardiac death, death due to heart failure, death due to stroke, death due to cardiovascular procedures, death due to cardiovascular hemorrhage, and death due to other cardiovascular causes

    3. the incidence of myocardial infraction [7 days, 30 days and 1 year post-CABG]

      According to the 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials, including CABG-related MI, non CABG-related MI, silent MI and unknown type.

    4. the incidence of repeat revascularization [7 days, 30 days and 1 year post-CABG]

      any PCI and CABG.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Patients who received CABG at the Department of Cardiac Surgery in our hospital from March 2020 to March 2021.

    2. Surgery that patients received includes both isolated and combined CABG surgery.

    3. Includes both cardiopulmonary and non-cardiopulmonary bypass.

    Exclusion Criteria:
    1. Without complete preoperative examination data, such as carotid-cerebral artery CTA, head CT imaging results and so on.

    2. Without complete baseline medical history and 7 day post-surgery record.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai Shanghai China 200025

    Sponsors and Collaborators

    • Ruijin Hospital

    Investigators

    • Principal Investigator: Qiang Zhao, MD, Ruijin Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Qiang Zhao,MD, Professor and Director, Department of Cardiovascular Surgery, Vice President, Ruijin Hospital, Ruijin Hospital
    ClinicalTrials.gov Identifier:
    NCT05036044
    Other Study ID Numbers:
    • KY-2021127
    First Posted:
    Sep 5, 2021
    Last Update Posted:
    Mar 15, 2022
    Last Verified:
    Mar 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Qiang Zhao,MD, Professor and Director, Department of Cardiovascular Surgery, Vice President, Ruijin Hospital, Ruijin Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 15, 2022